Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD Alone
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors
Interventions: DRUG: TAS-102|DRUG: Trifluridine
Sponsor: Taiho Oncology, Inc.